OMVYENCE
Live / Applied — Fourth extension granted (statement of use) (as of 10 Sept 2025)
What this means for you
Not registered yet, but its 02 Jun 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88943920
- Mark type
- Stylized text
- Filed
- 02 Jun 2020
- Published for opposition
- 22 Aug 2023
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of autoimmune diseases and disorders
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 11 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2025 — SOU EXTENSION 4 GRANTED
- 10 Sept 2025 — SOU EXTENSION 4 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2025 — SOU EXTENSION 3 GRANTED
- 13 Mar 2025 — SOU EXTENSION 3 FILED
- 13 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2024 — SOU EXTENSION 2 GRANTED
- 08 Oct 2024 — SOU EXTENSION 2 FILED
- 08 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2024 — SOU EXTENSION 1 GRANTED
- 20 Mar 2024 — SOU EXTENSION 1 FILED